News
Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks and even land you in the hospital. Medical experts want you to know that there are steps you ...
14d
Clinical Trials Arena on MSNVaxcyte stock sinks despite Phase II IPD vaccine trial successVaxcyte is awaiting data from another vaccine candidate for invasive pneumococcal disease (IPD) before advancing to Phase III ...
The company is adopting a "portfolio strategy" to pneumococcal disease, with "tailored…vaccines to meet the specific needs of different populations," said Dr Eliav Barr, the drugmaker's chief ...
The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease ...
Healthcare providers, public health officials and policymakers need to develop a greater understanding of the serious health impact of pneumococcal disease in elderly adults. In addition to ...
To get the word out about the expanded guidelines and the risk of pneumococcal disease, Pfizer this month launched a campaign focused on reaching the 50-plus crowd via social and digital channels ...
EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults “Pneumococcal disease continues to pose a significant risk for adults in Europe, among adults who are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results